Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

The Department of Defense Education Activity continues implementing innovative strategies to ensure increasing levels of ...

The firm, founded in 2024, focuses its investments on emerging and enabling technologies like advanced manufacturing and AI.

Donald Trump’s media company, Trump Media & Technology Group, has filed to trademark a series of investment products focused ...

In addition to the calls to cull or modify the passenger protections, IATA asked Trump to review the mandatory pilot ...

Mario Paredes, general director of SOMOS Community Care, proclaims, is in tune with Pope Francis: “No to deportations! Yes to ...

Montclair, NJ, Feb. 14, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) today issued the following Q4 2024 Shareholder Letter: ...

The US president's executive order weaponises the post-9/11 'terrorism' framework to detain migrants at the notorious prison ...

Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases -WAYNE, Pa., Feb. 12, 2025 ...

Greetings, and welcome to the Know Labs First Quarter 2025 Earnings Conference Call. Please note, this conference call is being recorded. I will now turn the conference over to Ron Erickson, Know Labs ...

EXCLUSIVE: Republican Rep. Andy Barr’s decision on whether to run for U.S. Senate in Kentucky will be made "independent of the decisions that others make, including Sen. Mitch McConnell," he told Fox ...

Q4 2024 Earnings Call Transcript February 11, 2025 IPG Photonics Corporation misses on earnings expectations. Reported EPS is ...